These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16292112)

  • 1. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 2. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

  • 3. Quillivant XR--an extended release oral suspension of methylphenidate.
    Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227
    [No Abstract]   [Full Text] [Related]  

  • 4. Transdermal methylphenidate system: old wine in a new bottle.
    Bukstein OG
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full-day ADHD symptom control that "lasts from home to homework".
    Pediatr Nurs; 2000; 26(6):634-5. PubMed ID: 12026370
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting.
    Pelham WE; Waxmonsky JG; Schentag J; Ballow CH; Panahon CJ; Gnagy EM; Hoffman MT; Burrows-MacLean L; Meichenbaum DL; Forehand GL; Fabiano GA; Tresco KE; Lopez-Williams A; Coles EK; González MA
    J Atten Disord; 2011 Jan; 15(1):28-35. PubMed ID: 20439487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
    Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting.
    Warshaw EM; Paller AS; Fowler JF; Zirwas MJ
    Clin Ther; 2008 Feb; 30(2):326-37. PubMed ID: 18343271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical inquiries. Does increasing methylphenidate dose aid symptom control in ADHD?
    Ibay AD; Bascelli LM; Graves RS; Hill J
    J Fam Pract; 2003 May; 52(5):400, 403. PubMed ID: 12737774
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular effects of methylphenidate.
    Daniels SR
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
    McGough JJ; Wigal SB; Abikoff H; Turnbow JM; Posner K; Moon E
    J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 16. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 17. A dose-ranging study of a methylphenidate transdermal system in children with ADHD.
    Pelham WE; Manos MJ; Ezzell CE; Tresco KE; Gnagy EM; Hoffman MT; Onyango AN; Fabiano GA; Lopez-Williams A; Wymbs BT; Caserta D; Chronis AM; Burrows-Maclean L; Morse G
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):522-9. PubMed ID: 15908834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate and chromosome damage.
    Jacobson-Kram D; Mattison D; Shelby M; Slikker W; Tice R; Witt K
    Cancer Lett; 2008 Feb; 260(1-2):216-8. PubMed ID: 18055105
    [No Abstract]   [Full Text] [Related]  

  • 19. Need for bedtime dose of ritalin.
    Rogers WB
    Pediatrics; 1996 Aug; 98(2 Pt 1):314. PubMed ID: 8692642
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.
    Elia J; Wilson Z; La Porta LS; Algon SA; Prowler ML; Cartwright ST; McKenna PA; Laracy S; Takeda T; Borgmann-Winter K
    Expert Rev Clin Pharmacol; 2011 May; 4(3):311-28. PubMed ID: 22114778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.